Daily Stock Analysis, ATRC, AtriCure Inc, priceseries

AtriCure Inc. Daily Stock Analysis
Stock Information
Open
21.10
Close
20.71
High
21.30
Low
20.70
Previous Close
21.07
Daily Price Gain
-0.36
YTD High
23.95
YTD High Date
May 8, 2017
YTD Low
14.78
YTD Low Date
Jan 23, 2017
YTD Price Change
1.51
YTD Gain
7.86%
52 Week High
23.95
52 Week High Date
May 8, 2017
52 Week Low
13.45
52 Week Low Date
Aug 8, 2016
52 Week Price Change
5.80
52 Week Gain
38.90%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 9. 2015
18.41
Mar 31. 2015
20.46
16 Trading Days
11.14%
Link
LONG
Nov 7. 2016
17.50
Nov 17. 2016
18.59
8 Trading Days
6.24%
Link
LONG
Apr 24. 2017
20.18
May 11. 2017
21.67
13 Trading Days
7.36%
Link
Company Information
Stock Symbol
ATRC
Exchange
NasdaqGM
Company URL
www.atricure.com
Company Phone
513-755-4100
CEO
Michael H. Carrel
Headquarters
Ohio
Business Address
7555 INNOVATION WAY, MASON, OH 45040
Sector
separate tissues to provide access to key anatomical structures that are targeted for ablation; and Estech cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. AtriCure sells its products through independent distributors and direct sales personnel. The company was founded in 2000 and is headquartered in Mason, Ohio.
Industry Category
Health Services
Industry Group
Medical Instruments & Supplies
CIK
0001323885
About

AtriCure, Inc. is an atrial fibrillation solutions partner, which engages in the provision of products, professional education, and support for clinical science to reduce the economic and social burden of atrial fibrillation. Its products include radiofrequency ablation, pacing, and sensing, cryo, atriclip devices, soft tissue dissection system, estech valve instrumentation, and cart configurations. The company was founded by Michael D. Hooven on October 31, 2000 and is headquartered in West Chester, OH.

Description

AtriCure, Inc. provides atrial fibrillation solutions to medical centers in the United States and internationally. The company offers Isolator Synergy and Isolator Synergy Access clamps for the treatment of persistent and long-standing persistent atrial fibrillation concomitant to other open-heart surgical procedures, such as coronary artery bypass grafting and/or valve replacement or repair; COBRA Fusion surgical ablation system to combine bipolar temperature-controlled radio frequency energy control with monopolar energy; and EPi-Sense guided coagulation system used for the temporary cardiac signal sensing and recording during surgery. It also provides SUBTLE cannula, an access device and conduit for the ablation device and endoscope to enable a closed chest endoscopic approach; multifunctional pens that allow surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and linear ablation devices, which enable physicians to create an expanded cardiac ablation lesion set. In addition, the company offers cryoICE cryoablation system used to ablate cardiac tissue for the treatment of cardiac arrhythmias and to provide temporary pain relief to thoracic surgery patients via ablation of peripheral nerves; AtriClip system used to occlude the left atrial appendage by mechanically clamping the appendage; Lumitip dissector to separate tissues to provide access to key anatomical structures that are targeted for ablation; and Estech cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. AtriCure sells its products through independent distributors and direct sales personnel. The company was founded in 2000 and is headquartered in Mason, Ohio.